Skip to content

LIMBO : Breast Reconstruction by Lipomodeling Alone or With Flap: Evaluation in Franche-Comté

Breast Reconstruction by Lipomodeling Alone or With Flap: Evaluation in Franche-Comté

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06101732
Acronym
LIMBO
Enrollment
140
Registered
2023-10-26
Start date
2022-05-05
Completion date
2022-10-13
Last updated
2023-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast Cancer, Surgery

Keywords

lipodelling, breast reconstruction

Brief summary

The Limbo study is a retrospective descriptive study which aims to establish the current state of breast reconstruction surgery at the Besançon University Hospital and Hôpital Nord Franche-Comté, between October 2017 and December 2021.

Interventions

None listed

Sponsors

Centre Hospitalier Universitaire de Besancon
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to No maximum

Inclusion criteria

* Patient who has undergone breast reconstruction using lipomodelling alone or in association with a flap (greater dorsal, DIEP Deep Inferior Epigastric Perforator flap or TRAM Tranverse Rectus Abdominis Myocutaneous Flap), since October 2017. Patient whose follow-up in plastic surgery is considered completed (final result obtained, patient lost to follow-up or not wishing to continue) at the time of data collection.

Exclusion criteria

* Patient under 18 at first consultation * Opposition of the patient to the collection of her data

Design outcomes

Primary

MeasureTime frameDescription
number of surgical procedures according to the type of breast reconstruction using lipomodelling alone or in combination with a flapBetween october 2017 and 2022number of surgical procedures

Secondary

MeasureTime frameDescription
description of patients' Body Mass Indexat inclusionBody Mass Index
description of patients' menopause statusat the time of data collectionmenopause status
description of patients' smoking statusat inclusionsmoking status
description of patients' diabetes or other medical conditionat inclusion
description of patients' relevant medical historyat inclusionrelevant medical history
description of patients' ageat inclusionpatient age
description of patients' type of cancerat inclusioncancer histology
description of patients' type of surgical treatmentat inclusiontype of breast reconstruction using lipomodelling alone or in combination with a flap
description of patients' Type of treatment associated with surgeryat inclusionType of treatment associated with surgery
description of Time elapsed between mastectomy and reconstructionat inclusionnumber of month between the date of mastectomy and date of reconstruction
description of patients' History of breast surgeryat inclusionhsitory of breast surgery

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 6, 2026